Hubert Walinski
Director/Board Member at CIPHER PHARMACEUTICALS INC.
Net worth: - $ as of 2024-03-30
Profile
Hubert Walinski is currently an Independent Director at Cipher Pharmaceuticals, Inc. and the Chief Scientific Officer at Aic Global Holdings, Inc. Previously, he worked as the Head-Medical Respiratory, Immunology & Vaccines at AstraZeneca Canada, Inc. Mr. Walinski holds a doctorate degree from the University of British Columbia, which he obtained in 2007.
He also has an undergraduate degree from McMaster University, which he received in 2001.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-21 | 0 ( -.--% ) | - $ | 2024-03-30 |
Hubert Walinski active positions
| Companies | Position | Start |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Director/Board Member | 2023-06-20 |
| Aic Global Holdings, Inc. | Chief Tech/Sci/R&D Officer | 2021-07-31 |
Former positions of Hubert Walinski
| Companies | Position | End |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 2021-06-30 |
Training of Hubert Walinski
| University of British Columbia | Doctorate Degree |
| McMaster University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
| Aic Global Holdings, Inc. |
- Stock Market
- Insiders
- Hubert Walinski
